Fig. 1From: Use of computed tomography-derived body composition to determine the prognosis of patients with primary liver cancer treated with immune checkpoint inhibitors: a retrospective cohort studyFlowchart of the study patient selection process. PLC primary liver cancer, ICI immune checkpoint inhibitor, CT computed tomography, MRI Magnetic Resonance ImagingBack to article page